Clinical Trial Update: CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates the Phase 1/Phase 2 safety and efficacy study of CAB-AXL-ADC in adult and adolescent patients with Undifferentiated Pleomorphic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxofibrosarcoma
• Undifferentiated Pleomorphic Sarcoma

Drugs mentioned

• CAB-AXL-ADC

Snippet

Sponsor: BioAtla, Inc. | Conditions: Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 1, Phase 2 | Status: COMPLETED